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We report a very rare case of trichilemmal carcinoma (TLC) involving the upper eyelid. To the best of our 
knowledge, this is the first report of trichilemmal carcinoma of the upper eyelid in Korea. A 51-year-old man 
presented to our hospital complaining of a bloody discharge from his left upper eyelid. He had a soft and lobulated 
mass on the palpebral conjunctiva. An incisional biopsy revealed trabecular growth of tumor cells with clear 
cytoplasm, prominent nucleoli, frequent mitoses, and foci of trichilemmal keratinization. Immunohistochemically, 
the lesion was positive for p53 and negative for CD 34. A diagnosis of TLC was made, and total excision of the 
mass and reconstruction of the eyelid were performed. Trichilemmal carcinoma is a rare malignant tumor, though 
it appears to be an indolent neoplasm with no metastatic potential. The treatment of choice for trichilemmal 
carcinoma of the eyelid is complete excision with tumor-free margins due to the locally invasive nature of the 
lesion. 
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Trichilemmal carcinoma (TLC) is an uncommon malignant 
adnexal tumor that originates from the external hair sheath.
1 
Trichilemmal carcinoma has a benign clinical course, but 
exhibits a malignant and invasive histological appearance.
2 
Eyelid involvement of TLC has been only rarely reported. 
Here, we report the first Korean case of TLC involving the 
upper eyelid. 
Case report
A 51-year-old man presented with bloody discharge from 
his left upper eyelid that had begun 2 to 3 days prior to prese- 
ntation. One month prior to visiting our hospital, he had no-
ticed the presence of a nontender, palpable, movable nodule 
that had not changed in size since discovery (Fig. 1). Swe- 
lling of the left upper lid was apparent. 
Slit-lamp examination revealed a 0.5×0.5 cm-sized protrud-
ing lesion of the left upper palpebral conjunctiva. The mass 
was slightly yellow and was composed of multiple lobules 
(Fig. 2). An incisional biopsy was performed. 
On incisional biopsy, a yellowish solid mass was observed. 
The mass demonstrated a trabecular growth pattern of tumor 
cell nests characterized by clear cytoplasm, prominent 
nucleoli, frequent mitoses, few atypical tripolar mitoses, 
and focal necrosis. There were also foci of trichilemmal 
keratinization (Fig. 3). On immunohistochemical staining, 
the tumor cells were diffusely distributed and were strongly 
positive for p53, but were negative for CD 34 (Fig. 4). Given 
the histological and immunohistochemical findings, the 
lesion was determined to be a TLC. 
The mass was completely excised with a pentagonal 
wedge resection of the upper lid, including a 5-mm safety 
margin, and the eyelid was reconstructed. The mass lesion 
was first outlined in a pentagonal shape and then excised; the 
excision included the surrounding palpebral conjunctiva. 
Tumor-free margins were ensured by frozen section analysis 
(Fig. 5A). The posterior lamella was reconstructed with a 
sliding tarsoconjunctival flap, and the anterior lamella was 
repaired with a myocutaneous advancement flap (Fig. 
5B-5D). After completion of the procedure, a reverse Frost 
suture was inserted into the center of the upper eyelid to 
prevent corneal exposure.
At the six month follow-up, there was no evidence of local 
recurrence or metastasis.
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Fig. 1. The patient had a swelling of the upper eyelid and a palpable, nontender, movable mass on the left eyelid.
A B
Fig. 2. A yellowish, soft, multi-lobulated mass is shown. The mass protrudes through the lateral end of the left upper palpebral conjunctiva. 
(A) Gross view. (B) Slit-lamp view.
Trichilemmal carcinoma was first described in 1976 as “a 
histologically invasive, cytologically atypical, clear cell neo-
plasm of adnexal keratinocytes which is in continuity with 
the epidermis and/or follicular epithelium.”
3  In most pa-
tients, the tumor typically occurs on sun‐exposed areas of the 
face and scalp,
1,2,4,5  but is rare on the eyelid.
5  Trichilemmal 
carcinoma on the eyelid was first described in 1993 in a 
95‐year‐old woman.
5,6 
Trichilemmal carcinoma typically affects individuals aged 
40 years and older.
7,8 Trichilemmal carcinoma can have a 
grossly papular, nodular, or exophytic appearance.
2,8,9 All 
TLCs reported to date have been less than 2 cm in diameter.
2,3 
Lai and colleagues
10 reported an induration of the eyelid 
with a small area of ulceration and keratosis, but a normal 
conjunctiva. In previous reports,
5,10,11 there were no significant 
changes of the conjunctiva; in the current case however, the 
upper lid mass completely penetrated into the inner side of 
the upper lid and was seen on the conjunctival side on 
slit-lamp examination. 
Histopathologically, TLC demonstrates a lobular prolifera-
tion centered on pilosebaceous structures and is composed 
of clear cells that are characterized by clear cytoplasm and 
prominent nucleoli. Trichilemmal carcinoma exhibits 
trichilemmal keratinization with an abrupt or pagetoid 
interface and dermal invasion.
8-10 
Malignant proliferating trichilemmal tumors (PTTs) are 
often confused with TLC. However, PTT is not synonymous 
with TLC.
3,6,9 Proliferating trichilemmal tumors usually arise 
in a pre-existing trichilemmal cyst and are frequently confined 
to the scalp. Proliferating trichilemmal tumors are larger 
than TLCs (with a diameter of up to 25 cm). Proliferating 
trichilemmal tumors demonstrate sharply circumscribed 
convoluted lobules with pushing margins, deep dermal 
extensions, extensive areas of tumor cell necrosis, abrupt 
keratinization, minimal pleomorphism, low mitotic activity, 
and foci indistinguishable from a trichilemmal cyst.
3,6 Prol- 
iferating trichilemmal tumors are apt to recur and to meta- 
stasize, as distinct from the behavior of TLCs.
6,9
Trichilemmal carcinoma must be differentiated from other 
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Fig. 3. Histology of the mass. (A) The section revealed a trabecular 
growth pattern of tumor cell nests (H&E, ×40). (B, C) The cells 
were characterized by clear cytoplasm, prominent nucleoli, fre-
quent mitoses, few atypical tripolar mitoses, and focal necrosis. 
There were also foci of trichilemmal keratinization (black arrow) 
(B: H&E, ×100; C: H&E, ×400). 
AB
Fig. 4. Immunohistochemical staining of the mass. (A) Negative staining for CD 34. (B) Strongly positive staining for p53. Korean J Ophthalmol Vol.23, No.4, 2009
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Fig. 5. Mass excision and reconstruction of the defect. (A) Complete mass excision using a pentagonal shape. Tumor-free margins were con-
firmed by frozen section biopsy. (B) Reconstruction of the posterior lamella with a tarsoconjunctival sling. (C) Reconstruction of the anterior 
lamella with a myocutaneous advancement flap. (D) Complete closure of the defect.
cell carcinoma (BCC), but zones of clear cells are not 
sufficient to diagnosis conventional BCC.
9,10 Squamous cell 
carcinoma demonstrates cellular atypia and cells with 
clear cytoplasm, similar to TLC, but differs from TLC in the 
absence of trichilemmal keratinization or lobular prolifera-
tion.
7,10 Also, TLC resembles trichilemmoma in the presence 
of a plate-like endophytic nodule extending into the dermis, 
but differs with respect to the occurrence of frequent mitosis 
or cellular atypia.
1
p53 tumor suppressor gene mutations are often found in 
patients with nonmelanoma skin cancer. Complete loss of p53 
on immunohistochemical staining represents the malignant 
transformation of PTT.
11 Also, focal staining for the presence 
of CD 34 is a marker of differentiation from the outer hair 
sheath. However, the tumor of the current patient was 
negative for CD 34, indicating an undifferentiated tumor cell 
type.
12,13
Trichilemmal carcinoma is locally invasive and, histologi-
cally, appears to have high-grade mitotic potential. However, 
TLC generally has a benign clinical course, and there is no 
evidence of recurrence after complete excision.
2,7,9,10
Masayuki et al.
11 reported a case of TLC of the upper 
eyelid that was treated with full dose irradiation. However, 
the tumor recurred and invaded the orbit. The tumor was 
resected in a procedure involving the eyelid and orbital 
contents. At the 29 month follow-up, there was no evidence 
of local recurrence or metastasis. 
Consequently, upon presentation of an indurated nodule or 
an ulcerated mass on the eyelid, it is necessary to consider the 
possibility of a cancerous lesion.
2,6,8 Trichilemmal carcinoma 
should be considered in the differential diagnosis of an 
eyelid mass. Trichilemmal carcinoma is a malignant tumor 
that usually does not metastasize, despite local regional 
recurrence.
1,5,14 It is important to perform a total excision of 
the tumor mass, with tumor-free margins, and to offer careful 
follow-up to all patients.
1,10,12 
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